Latest News
French private investment firm Ardian has completed the acquisition of the entire share capital of Verne, a data centre platform headquartered in the UK and diversified across Northern Europe, from investment trust Digital 9 Infrastructure, in a deal worth up to £450m.
Renewable energy infrastructure investor Excelsior Energy Capital has sold a portfolio of 38 solar energy and solar plus storage projects from its Excelsior Renewable Energy Investment Fund I portfolio to BlackRock’s Evergreen Infrastructure Partners Fund.
Sagard, a global multi-strategy alternative investment fund with over $25bn in AUM across venture capital, private equity, private credit, real estate and royalties, is to acquire a 40% stake in US-based CLO manager HalseyPoint.
Goldman Sachs Asset Management and Sixth Street Partners are leading a $655m debt financing package deal for global alternative investment firm HIG Capital to fund a potential purchase of mechanical and industrial cleaning company USA DeBusk, according to a report by Bloomberg.
Global law firm Taylor Wessing has appointed Shervin Shameli as Partner within its London private equity and fund formation team. Shameli joins from Reed Smith, where he was Co-Head of its private funds formation group in London.
Sustainable Development Capital has appointed Philip Doyle, a 20-year energy transition and infrastructure investment industry veteran, as Co-Fund Manager of the Green Energy Solutions Fund and Managing Director of its Dublin office.
Investment platform Corinthia Global Management is hiring a 20-plus private credit team from $381m global investment management firm Barings, according to a report by Bloomberg citing people with knowledge of the matter.
Global buyout firm KKR & Co has agreed a public takeover of German renewable energy company Encavis, valuing the company at €2.8bn, according to a report by Reuters. Elbe Bidco, an investment vehicle owned by KKR, has offered €17.50 per share.
Paris-based private equity firm Andera Partners has agreed to sell its portfolio company, Amolyt Pharma, a global biopharmaceutical company specialising in developing therapeutic peptides for rare endocrine and related diseases, to British-Swedish multinational pharma AstraZeneca, in a deal worth up to $1.05bn.
European private equity firm HQ Capital has opened an office in Singapore and appointed Michael Hu as Managing Director and Head of Asia. In his new role, Hu will lead the firm’s investment and business development activities in Asia and will also join its global executive committee.
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
